Financials Bhang Inc.

Equities

BHNG

CA08862K1057

Pharmaceuticals

Market Closed - Canadian Securities Exchange 17:43:04 04/05/2023 BST 5-day change 1st Jan Change
0.02 CAD -.--% Intraday chart for Bhang Inc. -.--% -.--%

Valuation

Fiscal Period: December 2019 2020 2021
Capitalization 1 13.03 6.564 16.56
Enterprise Value (EV) 1 13.29 6.704 15.6
P/E ratio -0.76 x -1.36 x -4.16 x
Yield - - -
Capitalization / Revenue 2.73 x 4.03 x 13.1 x
EV / Revenue 2.78 x 4.12 x 12.3 x
EV / EBITDA -1.52 x -2.17 x -5.32 x
EV / FCF 19,140,183 x -4,664,899 x -15,963,584 x
FCF Yield 0% -0% -0%
Price to Book -20 x -4.66 x -63.6 x
Nbr of stocks (in thousands) 112,890 152,018 232,599
Reference price 2 0.1154 0.0432 0.0712
Announcement Date 30/06/20 23/06/21 31/05/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021
Net sales 1 1.979 1.639 4.778 1.627 1.266
EBITDA 1 -0.316 -1.536 -8.77 -3.084 -2.933
EBIT 1 -0.3396 -1.565 -8.84 -3.144 -2.978
Operating Margin -17.16% -95.5% -185.02% -193.18% -235.13%
Earnings before Tax (EBT) 1 -0.5774 -1.539 -15.08 -4.422 -3.298
Net income 1 -0.5774 -1.539 -15.08 -4.418 -3.298
Net margin -29.17% -93.89% -315.59% -271.48% -260.41%
EPS 2 -5.771 -13.21 -0.1527 -0.0317 -0.0171
Free Cash Flow - -4.43 0.6944 -1.437 -0.9773
FCF margin - -270.36% 14.53% -88.31% -77.17%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 10/07/19 10/07/19 30/06/20 23/06/21 31/05/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021
Net Debt 1 0.84 - 0.26 0.14 -
Net Cash position 1 - 1.08 - - 0.96
Leverage (Debt/EBITDA) -2.672 x - -0.0302 x -0.0454 x -
Free Cash Flow - -4.43 0.69 -1.44 -0.98
ROE (net income / shareholders' equity) - -63.7% -652% 433% 401%
ROA (Net income/ Total Assets) - -20.8% -133% -95.3% -103%
Assets 1 - 7.412 11.31 4.635 3.195
Book Value Per Share 2 -4.470 45.30 -0.0100 -0.0100 -0
Cash Flow per Share 2 1.550 4.220 0 0 0
Capex 1 0 0.19 0.25 0.09 0.04
Capex / Sales 0.04% 11.86% 5.21% 5.41% 2.98%
Announcement Date 10/07/19 10/07/19 30/06/20 23/06/21 31/05/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA